Your browser doesn't support javascript.
loading
Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).
Schneider, Tamás; Rosta, András; Losonczy, Hajna; Radványi, Gáspár; Ujj, György; Egyed, Miklós; Illés, Árpád; Jakucs, János; Szerafin, László; Gasztonyi, Zoltán; Masszi, Tamás; Iványi, János; Demeter, Judit; Dombi, Péter; Tóth, Antal; Borbényi, Zita.
Afiliación
  • Schneider T; National Institute of Oncology, Department of Medical Oncology "A" and Hematology, Lymphoma Center, Ráth György u. 7-9, Budapest, 1122, Hungary. schneidertamas@freemail.hu.
  • Rosta A; National Institute of Oncology, Department of Medical Oncology "A" and Hematology, Lymphoma Center, Ráth György u. 7-9, Budapest, 1122, Hungary.
  • Losonczy H; I. Department of Internal Medicine, University of Pécs, Ifjúság út 13, Pécs, 7624, Hungary.
  • Radványi G; II. Department of Internal Medicine, Semmelweis Hospital, Csabai kapu 9-11, Miskolc, 3529, Hungary.
  • Ujj G; I. Department of Internal Medicine, Jász-Nagykun-Szolnok County Hetényi Géza Hospital, Tószegi út 21, Szolnok, 5000, Hungary.
  • Egyed M; Department of Internal Medicine and Hematology, Kaposi Mór Hospital, Tallián Gyula u. 20-34, Kaposvár, 7400, Hungary.
  • Illés Á; Faculty of Medicine, Department of Hematology, University of Debrecen, Nagyerdei krt. 98, Debrecen, 4032, Hungary.
  • Jakucs J; I. Department of Internal Medicine, Békés County Pándy Kálmán Hospital, Semmelweis u. 1, Gyula, 5700, Hungary.
  • Szerafin L; Department of Haematology, Szabolcs-Szatmár-Bereg County Jósa András Hospital, Szent István u. 68, Nyíregyháza, 4400, Hungary.
  • Gasztonyi Z; II. Department of Internal Medicine and Hematology, Petz Aladár County Hospital, Vasvári Pál u. 2-4, Gyor, 9024, Hungary.
  • Masszi T; Department of Hematology, Szent István and Szent László Hospital, Nagyvárad tér 1, Budapest, 1097, Hungary.
  • Iványi J; 3rd Department of Internal Medicine, Semmelweis University, Kútvölgyi út 4, Budapest, 1125, Hungary.
  • Demeter J; Department of Hematology, Vas County Markusovszky Hospital, Markusovszky L. u. 5, Szombathely, 9700, Hungary.
  • Dombi P; I. Department of Internal Medicine, Semmelweis University, Korányi Sándor u. 2/A, Budapest, 1083, Hungary.
  • Tóth A; Department of Hematology, Szent Borbála Hospital, Dózsa György út 77, Tatabánya, 2800, Hungary.
  • Borbényi Z; IV. Department of Internal Medicine, Tolna County Balassa János Hospital, Béri Balogh Ádám u. 5-7, Szekszárd, 7100, Hungary.
Pathol Oncol Res ; 24(2): 199-205, 2018 Apr.
Article en En | MEDLINE | ID: mdl-28432650
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma Folicular / Quimioterapia de Mantención / Rituximab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pathol Oncol Res Asunto de la revista: NEOPLASIAS / PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma Folicular / Quimioterapia de Mantención / Rituximab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pathol Oncol Res Asunto de la revista: NEOPLASIAS / PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Suiza